Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Backman

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Pharmacology|August 22, 2000
Effect of fluconazole on plasma fluvastatin and pravastatin concentrationsT Kantola, J T Backman, M Niemi, et al.
European Journal of Clinical Pharmacology|November 9, 2001
Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivoK Villikka, T Varis, J T Backman, et al.
Clinical Pharmacology and Therapeutics|May 10, 2013
Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metaboliteA M Filppula, A Tornio, M Niemi, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Triazolam is ineffective in patients taking rifampinK Villikka, K T Kivistö, J T Backman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
Diabetologia|August 5, 2003
Gemfibrozil considerably increases the plasma concentrations of rosiglitazoneM Niemi, J T Backman, M Granfors, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humansJ S Wang, J T Backman, P Taavitsainen, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Dose of midazolam should be reduced during diltiazem and verapamil treatmentsJ T Backman, K T Olkkola, K Aranko, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastT Karonen, A Filppula, J Laitila, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
Plasma concentrations of active simvastatin acid are increased by gemfibrozilJ T Backman, C Kyrklund, K T Kivistö, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|August 22, 2000
Effect of fluconazole on plasma fluvastatin and pravastatin concentrationsT Kantola, J T Backman, M Niemi, et al.
European Journal of Clinical Pharmacology|November 9, 2001
Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivoK Villikka, T Varis, J T Backman, et al.
Clinical Pharmacology and Therapeutics|May 10, 2013
Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metaboliteA M Filppula, A Tornio, M Niemi, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Triazolam is ineffective in patients taking rifampinK Villikka, K T Kivistö, J T Backman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
Diabetologia|August 5, 2003
Gemfibrozil considerably increases the plasma concentrations of rosiglitazoneM Niemi, J T Backman, M Granfors, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humansJ S Wang, J T Backman, P Taavitsainen, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Dose of midazolam should be reduced during diltiazem and verapamil treatmentsJ T Backman, K T Olkkola, K Aranko, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastT Karonen, A Filppula, J Laitila, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
Plasma concentrations of active simvastatin acid are increased by gemfibrozilJ T Backman, C Kyrklund, K T Kivistö, et al.
Pageof 7